Comprehensive panels for hereditary cancer
For cancer patients and individuals with a family history of multiple cancers, in-depth genetic testing can determine whether the cancer is hereditary in origin. Our comprehensive hereditary cancer panels use next generation sequencing to evaluate dozens of genes for personalized insights into whether an individual carries a heritable, elevated risk for cancer. Patients identified with a hereditary cancer syndrome can benefit from directed treatment choices, personalized surveillance, and understanding of their cancer risks.
COMCP | Hereditary Common Cancer Panel
Test in focus
Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant genes, the panels provide clarity on diagnosis, prognosis, and treatment approaches.
Learn more about how to order these tests at your institution.